Viewing Study NCT00249730



Ignite Creation Date: 2024-05-05 @ 12:07 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00249730
Status: COMPLETED
Last Update Posted: 2021-02-01
First Post: 2005-11-03

Brief Title: Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function
Sponsor: Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization: Pfizer

Study Overview

Official Title: A Prospective Multicenter Parallel Group Study With A Single Blind Phase And A Double Blind Randomised Phase To Evaluate The Efficacy And Satisfaction Of Viagra Sildenafil Citrate High Dose 100mg Titration Compared With 50mg Dose In Men With Erectile Dysfunction
Status: COMPLETED
Status Verified Date: 2021-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the efficacy of Viagra dose titration to 100mg versus 50mg in men with erectile dysfunction based on responses to the IIEF questionnaire as measured at the beginning and at the end of double blind treatment comparing the group titrated to 100mg vs the group maintained on 50mg
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None